Cookie technology helps us bring you the best possible experience when you visit this website. Please let us know if you're happy to accept cookies. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.

en:

    • {%itemName%}
        {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%itemKeyName%} {%itemBadges%} {%arrowSpan%}
      {%selfProduct%}
    • {%itemName%}
      • {%countries%}
    • {%allMenuItem%}
      • {%languages%}


      • AbbVie Commitment to Neuroscience Video


       


      2023 EAN-Messoud Ashina Key Takeaways_1


       


      GMA AbbVie PRO 2022 EHC
      Symposium-Shifting Paradigm in Migraine Treatment_1


       


      How Do We Look at the Future
      of Migraine?-Pr. Patricia Pozo-Rosich-


       


      GMA AbbVie PRO 2022 EHC Symposium Insights of
      Migraine Drug Classes Mechanism of Action


       


      Improving Patient Pathways and 
      Standard of Care for Migraine


       


      Evolving Landscape of Migraine-Pr. Cristina Tassorelli


       


      Gepants MOA Video


       


      Migraine Disease State Video


       

      Our therapy areas
      Oncology
      Immunology
      Medical Information
       
      Additional info
      Privacy Notice
      Terms Of Use

       

      For Oman HCPs.

      Department of Pharmacovigilance & Drug information.

      Directorate General of pharmaceutical affairs and Drug control.

      Ministry of health, Sultanate of Oman

      Phone Nos:: 22357687 / 22357686

      Fax: 22358489

      Email: [email protected]

      Website:www.moh.gov.om

       

      This website is intended for Gulf Healthcare Professionals

      AbbVie Biopharmaceuticals GmbH.

       

      Suite 2901, U Bora Tower,Business Bay, Dubai, UAE

      PO Box:: 118052

      OFFICE : +971 4 5506100

      FAX: +971 4 5506101

      Patient Safety is our Priority, we will remain always by your side. For Reporting Adverse events Please Contact.

      [email protected] or Hotline: 00971564135746